MedTrace Logo

Personalized Virtual Reality Naturalistic Scenarios in Cognitive Impairment

NCT05863065 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 23

Last updated 2023-05-17

No results posted yet for this study

Summary

The goal of this feasibility study is to investigate the feasibility of a personalized naturalistic Virtual Reality scenario by assessing motion-sickness effects, engagement, pleasantness, and emotions felt considering a sample of individuals with cognitive impairment resident at the Azienda Pubblica di Servizi alla Persona (APSP) "Margherita Grazioli", a long-term care home in Trento (Italy) in collaboration with the Department of General Psychology - University of Padova (Italy) and the Centre for Health and Wellbeing-Fondazione Bruno Kessler (Italy). The current proof-of-concept and feasibility study is a one-session single-centre trial based on a mixed-methods approach inspired by the Obesity-Related Behavioral Intervention Trials (ORBIT) framework for the design (Phase Ib) of digital interventions and their preliminary testing (Phase IIa).

Conditions

Interventions

OTHER

Exposure to a Virtual Reality scenarios

Exposure to a personalized, relaxing Virtual Reality scenario deployed by a Head-mounted tool (Oculus Quest 2). The administration was deployed in one session.

Sponsors & Collaborators

  • Fondazione Bruno Kessler

    collaborator OTHER

  • Azienda Provinciale per i Servizi Sanitari, Provincia Autonoma di Trento

    collaborator OTHER

  • TrentinoSalute4.0

    collaborator OTHER

  • University of Padova

    lead OTHER

Principal Investigators

  • Susanna Pardini, PsyD · University of Padova

  • Caterina Novara, PhD · University of Padova

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-23
Primary Completion
2023-03-06
Completion
2023-03-06

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05863065 on ClinicalTrials.gov